High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
- Conditions
- Heart Transplant RecipientsPhysical Fitness
- Interventions
- Behavioral: Moderate TrainingBehavioral: High Intensity Interval Training
- Registration Number
- NCT01796379
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
Compared to end-stage heart failure, a patient's situation is usually greatly improved after a heart transplant (HTx), but the exercise capacity remains sub-normal, also long-term, ranging from 50 to 70% in most studies. While effective rehabilitation, including regular exercise, is considered an effective tool of improving health related quality of life (HRQoL) and prognosis of cardiac patients in general, the knowledge about and the effect of different rehabilitation programs among HTx recipients is limited. Exercise training is considered one of the most central parts in rehabilitation, but the mode of exercise used in different studies varies considerably. It is documented that high intensity interval training (HIT) has superior effects compared to training with moderate intensity in cardiac and heart failure patients. In contrast, HTx recipients have a denervated heart, and HIT had been considered unphysiological. However, the investigators have recently demonstrated highly beneficial effects on exercise capacity, muscle strength, body composition, reduced progression of cardiac allograft vasculopathy and HRQoL among long-term HTx recipients. In the present study the investigators want to test the hypothesis that systematic aerobic exercise with high intensity improve exercise capacity also in newly transplanted recipients, and secondarily that it gives favourable effects on the heart, peripheral circulation and a better HRQoL.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Clinically stable HTx recipients approximately 8-12 weeks after HTx.
- Age > 18 years, both sexes
- Received immunosuppressive therapy as per local protocol.
- Patient willing and capable of giving written informed consent for study participation and anticipated to be able to participate in the study for 9- 12 months.
- Unstable condition or postoperative complications
- Recent severe rejection episodes
- Physical disabilities which prevent participation
- Other diseases or disabilities that contradict/refrain from exercise.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Moderate Training Moderate Training Regular exercise training offered as usual care to all heart transplant recipients. High Intensity Interval Training High Intensity Interval Training -
- Primary Outcome Measures
Name Time Method Effect of exercise on peak oxygen uptake Baseline to one year Change in ml/kg/min
- Secondary Outcome Measures
Name Time Method Effect of exercise on health related quality of life Baseline to one year Change measured on visual analogue scales and questionnaires
Effect of exercise on chronotropic responses Baseline to one year Change in heart rate response, including changes in minimum and maximum heart rate and changes in chronotropic response index.
Effect of exercise on muscle strength Baseline to one year Change measured in Newtonmeter and Joule
Effect of exercise on endothelial function Baseline to one year Change in endothelial function measured by flow mediated dilatation and EndoPat
Effect of exercise on biomarkers Baseline to one year Neuroendocrine, inflammatory and immunological biomarkers.
Effect of exercise on safety and tolerability Baseline to 3 years follow-up Measured by number of serious adverse effects related to the intervention
Effect of exercise on myocardial function Baseline to one year Change in echocardiographic parametres such as stroke volume, cardiac index and ejection fraction.
Long-term effects of exercise Baseline to 3 years follow-up Long-term effects will be measured by all outcomes listed above, including number of serious adverse effects.
Effect of exercise on progression of coronary artery vasculopathy (CAV) Baseline to one year Change measured by intravascular ultrasound; change in maximum intimal thickness, total atheroma volume, percent atheroma volume and virtual histology.
Trial Locations
- Locations (3)
Sahlgrenska University Hospital
🇸🇪Gothenburg, Sweden
Oslo University Hospital Rikshospitalet
🇳🇴Oslo, Norway
Copenhagen University Hospital
🇩🇰Copenhagen, Denmark